Allelica, the global leader in multi-ancestry clinical polygenic risk score (PRS) testing, has been selected as the PRS testing collaborator for the PROACT 3 clinical trial at Mass General Brigham.

A polygenic risk score was able to detect a high proportion of clinically significant prostate cancer. Cancer would not have been detected in 71.8% of patients with the use of PSA or MRI screening.

For more than four decades, in vitro fertilization (IVF) has helped families have children. Scientists estimate that more than 10 million people worldwide have been born through IVF and related ...

Researchers have mapped how hundreds of everyday environmental and lifestyle exposures, from diet and pollution to social ...

India, April 5 -- Scientists caution that choosing embryos based on genetic scores raises urgent ethical risks and requires ...

Please provide your email address to receive an email when new articles are posted on . Researchers said common risk variants help explain why epilepsy occurs in some family members and not others.

Incorporating a polygenic risk score into prostate cancer screening could enhance the detection of clinically significant prostate cancer that conventional screening may miss, according to results of ...

Please provide your email address to receive an email when new articles are posted on . Researchers developed a multi-ancestry polygenic score using data from two genome-wide association studies.

“What makes the score so powerful is its ability to predict, before the age of five, whether a child is likely to develop obesity in adulthood, well before other risk factors start to shape their ...

A new study links telomere length and polygenic risk scores to IPF development, highlighting genetic drivers beyond rare variants. The role of polygenic risk scores in patients with idiopathic ...